Psychological counseling and therapy are among the interventions that may help adults with pulmonary hypertension (PH) manage depression and…
Articles by Marisa Wexler, MS
Tenax Therapeutics has been issued a U.S. patent covering oral levosimendan, also known as TNX-103, for the treatment…
Liquidia has licensed the rights in North America to L606, a novel inhaled formulation of treprostinil that’s being tested…
Janssen Pharmaceuticals has submitted an application in Europe asking regulatory authorities to approve the company’s combination therapy of macitentan…
Liqrev, a new liquid formulation of sildenafil designed for patients who have trouble swallowing tablets, is now available in…
Treatment with intravenous Revatio (sildenafil) can improve oxygen delivery and heart health in some premature babies with pulmonary hypertension,…
The outcomes used in clinical trials of pulmonary arterial hypertension (PAH) don’t fully reflect the priorities of patients and clinicians,…
Janssen Pharmaceuticals has submitted an application to the U.S. Food and Drug Administration (FDA) seeking approval of a combination…
Treatment with AER-901, an inhaled formulation of imatinib that Aerami Therapeutics is developing as a treatment for two forms…
Treatment with KER-012, an experimental therapy Keros Therapeutics is developing to treat pulmonary arterial hypertension (PAH), lowered markers of…
The proportion of people with pulmonary arterial hypertension (PAH) who start on a combination of medications after they’re diagnosed…
Gossamer Bio is planning to soon launch a Phase 3 clinical trial to test its experimental inhaled therapy seralutinib…